These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2866138)

  • 1. Famotidine: summary of preclinical safety assessment.
    Burek JD; Majka JA; Bokelman DL
    Digestion; 1985; 32 Suppl 1():7-14. PubMed ID: 2866138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical safety studies with terfenadine.
    Gibson JP; Huffmann KW; Newberne JW
    Arzneimittelforschung; 1982; 32(9a):1179-84. PubMed ID: 6129864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxicologic study on the antihypertensive agent urapidil].
    König J; Meier-Dörzenbach ED; Menge HG; Müller H; Padberg G; Petersen-Knoche C; Schäfer H
    Arzneimittelforschung; 1977; 27(10):1919-32. PubMed ID: 579102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preclinical toxicological evaluation of sumatriptan.
    Owen K; Hartley K; Tucker ML; Parkinson MM; Tweats DJ; Jackson MR
    Hum Exp Toxicol; 1995 Dec; 14(12):959-73. PubMed ID: 8962747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study.
    Morgan MY; Stambuk D
    Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famotidine: clinical applications of a new H2-receptor antagonist. Introduction.
    Texter EC
    Am J Med; 1986 Oct; 81(4B):1-2. PubMed ID: 2877567
    [No Abstract]   [Full Text] [Related]  

  • 7. A single nocte dose of famotidine in the treatment of duodenal ulcer.
    Qureshi H; Ahmad W; Zuberi SJ
    J Pak Med Assoc; 1989 Apr; 39(4):104-6. PubMed ID: 2568508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famotidine: an appraisal of its mode of action and safety.
    Berlin RG; Clineschmidt BV; Majka JA
    Am J Med; 1986 Oct; 81(4B):8-12. PubMed ID: 2877577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical toxicology of pirmenol hydrochloride.
    Martin RA; de la Iglesia FA
    Angiology; 1988 Mar; 39(3 Pt 2):299-306. PubMed ID: 3354930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
    Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
    Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis against acid aspiration syndrome. Single oral dose of H2-antagonist on the evening before elective surgery.
    Gallagher EG; White M; Ward S; Cottrell J; Mann SG
    Anaesthesia; 1988 Dec; 43(12):1011-4. PubMed ID: 2906783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Famotidine. Pharmacologic and clinical profile of the new histamine H2 receptor antagonist].
    Müller P; Dammann HG; Simon B
    Fortschr Med; 1986 Apr; 104(15):319-22. PubMed ID: 2872147
    [No Abstract]   [Full Text] [Related]  

  • 13. Famotidine in the USA: a review of efficacy studies.
    Gitnick G
    J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind controlled study.
    Paoluzi P; Torsoli A; Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Carratelli L; Cheli R
    Digestion; 1985; 32 Suppl 1():38-44. PubMed ID: 2866135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, double-blind study comparing famotidine with cimetidine in the treatment of active duodenal ulcer disease.
    Rodrigo L; Viver J; Conchillo F; Barrio E; Forné M; Zozaya JM; Alvarez A; Dieguez P; Muñoz M; Panés J
    Digestion; 1989; 42(2):86-92. PubMed ID: 2570005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute toxicity studies of ebrotidine.
    Grau MT; Romero A; Villamayor F; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):490-1. PubMed ID: 9205750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicologic evaluation of cefamandole nafate in laboratory animals.
    Wold JS; Welles JS; Owen NV; Gibson WR; Morton DM
    J Infect Dis; 1978 May; 137 Suppl():S51-S59. PubMed ID: 650004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children.
    Miyake S; Yamada M; Iwamoto H; Yamashita S; Sugio Y
    Clin Ther; 1987; 9(5):548-58. PubMed ID: 2889529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
    Baglioni A; Barbara L; Bianchi-Porro G; Blasi A; Canelli B; Cheli R; Dal Monte R; Dammann HG; Francavilla A; Hentschel E
    Z Gastroenterol; 1985 Dec; 23(12):665-9. PubMed ID: 2868581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
    Bianchi Porro G
    Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.